Systemic Lupus Erythematosus Perspective

 
 
  • Addressing Women's Concerns About the J&J Vaccine Reproductive-aged women are asking whether the J&J vaccine will be safe for them. What advice can clinicians give?
  • Lie of the Year: The Downplay and Denial of the Coronavirus Lies infected America in 2020. The very worst were not just damaging, but deadly.
  • Systemic Lupus Erythematosus Abstracts From ACR Convergence   Dr Michele Petri highlights abstracts on systemic lupus erythematosus from ACR 2020, including the effects of hydroxychloroquine on QTc length and use of belimumab and obinutuzumab on renal outcomes.
  • A 27-Year-Old Woman With Knee Pain and Facial Rash A 27-year-old woman presents with fatigue, joint pain, and facial rash. What study or investigation is the best next step?
  • ACR 2020 Read clinically focused news coverage of key developments from ACR 2020
  • Sex- and Gender-Informed Medicine: Why It Matters   Dr JoAnn Manson highlights key health and disease differences influenced by sex and gender.
  • DAPA-CKD: SGLT2 Inhibitors 'The Beta-Blockers for the Kidneys'   Nephrologists Jennie Lin and Leslie Gewin discuss the effects of dapagliflozin in patients with CKD. How do the DAPA-CKD findings fit with the CREDENCE data on SGLT2 inhibitors?
  • No Shame in Choosing Not to Be a COVID-19 Hero   A revealing FaceTime call with her mother, a fellow cardiologist, caused Lisa Rosenbaum to change course during the COVID-19 surge. The NEJM columnist discusses her reasoning with Michelle O'Donoghue.
  • Is COVID-19 Fueling the Fire of Opinion-Based Medicine? This pandemic is causing people to turn to the 'pseudosciences' in their desperation to quickly save the world, writes Harpreet Bajaj.
  • EULAR 2020 Read clinically focused news coverage of key developments from EULAR 2020
  • COVID-19 in People with Arthritis Dr Fotini Soliotis, consultant rheumatologist at Poole Hospital in Dorset, talks us through how COVID-19 affects arthritis patients and their treatments.
  • Skin Changes With COVID-19: What We Know and Don't Know Drs Graeme Lipper and Lindy Fox discuss the firestorm of new information describing dermatologic conditions associated with COVID-19 and the many questions still unanswered.
  • Treating Rheumatic Diseases in a COVID-19 Epicenter 'Should I stop my medication to lower my risk for infection?' Three NYC rheumatologists share what they know to answer this and other FAQs about COVID-19 and rheumatologic diseases.
  • Rheumatologists Challenged in the Era of COVID-19 Drs Kevin Deane and Duane Pearson discuss the challenges and opportunities the COVID-19 pandemic presents for rheumatologists and their patients.
  • Hydroxychloroquine Study Did Not Meet 'Expected Standard' The paper that appears to have triggered the Trump administration's obsession with hydroxychloroquine as a treatment COVID-19 has received a statement of concern from the publishers of the journal.
  • 2019 CVD Primary Prevention Guideline: 5 Things to Know Although CVD is a leading cause of death worldwide, most patients with CVD have modifiable risk factors. Drs Michos and Shahu look at key aspects of the 2019 ACC/AHA guideline on primary prevention of CVD.
  • SLE Highlights From the 2019 ACR Annual Meeting   Dr Michelle Petri of the Johns Hopkins Lupus Center reviews key studies related to systemic lupus erythematosus, presented at the 2019 annual meeting of the American College of Rheumatology.
  • ACR 2019 Read clinically focused news coverage of key developments from ACR 2019
  • A 25-Year-Old Woman With Depigmentation: USMLE Question A 25-year-old woman presents with progressive depigmentation on her hands over the past 3 years. Do you know the disease process at work?
  • A 42-Year-Old Woman With Swollen Eyes: USMLE Question A 42-year-old woman presents with swelling around both of her eyes. She has been urinating less and has also had fevers and joint pain. What's the diagnosis?